Treatment of chronic idiopathic urticaria with topical steroids: An open trial.

A R Ellingsen; K Thestrup-Pedersen

Treatment of chronic idiopathic urticaria with topical steroids: An open trial.

A R Ellingsen, K Thestrup-Pedersen

Department of Clinical Medicine - The Department of Dermatology and Venereology

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

20 Citations (Scopus)

Abstract

Twenty-three patients with chronic idiopathic urticaria and 3 patients with urticaria pigmentosa received a 2-week treatment with daily application of potent topical steroid using plastic occlusion. Seventy per cent of the chronic urticaria patients had a statistically significant, immediate response, which, however, did not last until the final evaluation after 1.5 years. Relapse occurred after on average 3 weeks, but 39% reported less severity. The 3 patients with urticaria pigmentosa remained free from attacks for 6 to 9 months, after which they gradually relapsed. Two women were diagnosed during the follow-up period to have a carcinoma of the breast, and one patient developed systemic lupus erythematosus.

Original language	English
Journal	Acta Dermato-Venereologica
Volume	76
Issue	1
Pages (from-to)	43-44
Number of pages	2
ISSN	0001-5555
Publication status	Published - Jan 1996

Keywords

Administration, Topical
Adolescent
Adult
Anti-Inflammatory Agents
Breast Neoplasms
Chronic Disease
Clobetasol
Female
Follow-Up Studies
Glucocorticoids
Humans
Lupus Erythematosus, Systemic
Male
Middle Aged
Occlusive Dressings
Recurrence
Retrospective Studies
Single-Blind Method
Surveys and Questionnaires
Treatment Outcome
Urticaria
Urticaria Pigmentosa

Cite this

@article{88932432d93b4078a853869226755bb2,

title = "Treatment of chronic idiopathic urticaria with topical steroids: An open trial.",

abstract = "Twenty-three patients with chronic idiopathic urticaria and 3 patients with urticaria pigmentosa received a 2-week treatment with daily application of potent topical steroid using plastic occlusion. Seventy per cent of the chronic urticaria patients had a statistically significant, immediate response, which, however, did not last until the final evaluation after 1.5 years. Relapse occurred after on average 3 weeks, but 39% reported less severity. The 3 patients with urticaria pigmentosa remained free from attacks for 6 to 9 months, after which they gradually relapsed. Two women were diagnosed during the follow-up period to have a carcinoma of the breast, and one patient developed systemic lupus erythematosus.",

keywords = "Administration, Topical, Adolescent, Adult, Anti-Inflammatory Agents, Breast Neoplasms, Chronic Disease, Clobetasol, Female, Follow-Up Studies, Glucocorticoids, Humans, Lupus Erythematosus, Systemic, Male, Middle Aged, Occlusive Dressings, Recurrence, Retrospective Studies, Single-Blind Method, Surveys and Questionnaires, Treatment Outcome, Urticaria, Urticaria Pigmentosa",

author = "Ellingsen, {A R} and K Thestrup-Pedersen",

year = "1996",

month = jan,

language = "English",

volume = "76",

pages = "43--44",

journal = "Acta Dermato-Venereologica",

issn = "0001-5555",

publisher = "Medical Journals Sweden AB",

number = "1",

}

TY - JOUR

T1 - Treatment of chronic idiopathic urticaria with topical steroids: An open trial.

AU - Ellingsen, A R

AU - Thestrup-Pedersen, K

PY - 1996/1

Y1 - 1996/1

N2 - Twenty-three patients with chronic idiopathic urticaria and 3 patients with urticaria pigmentosa received a 2-week treatment with daily application of potent topical steroid using plastic occlusion. Seventy per cent of the chronic urticaria patients had a statistically significant, immediate response, which, however, did not last until the final evaluation after 1.5 years. Relapse occurred after on average 3 weeks, but 39% reported less severity. The 3 patients with urticaria pigmentosa remained free from attacks for 6 to 9 months, after which they gradually relapsed. Two women were diagnosed during the follow-up period to have a carcinoma of the breast, and one patient developed systemic lupus erythematosus.

AB - Twenty-three patients with chronic idiopathic urticaria and 3 patients with urticaria pigmentosa received a 2-week treatment with daily application of potent topical steroid using plastic occlusion. Seventy per cent of the chronic urticaria patients had a statistically significant, immediate response, which, however, did not last until the final evaluation after 1.5 years. Relapse occurred after on average 3 weeks, but 39% reported less severity. The 3 patients with urticaria pigmentosa remained free from attacks for 6 to 9 months, after which they gradually relapsed. Two women were diagnosed during the follow-up period to have a carcinoma of the breast, and one patient developed systemic lupus erythematosus.

KW - Administration, Topical

KW - Adolescent

KW - Adult

KW - Anti-Inflammatory Agents

KW - Breast Neoplasms

KW - Chronic Disease

KW - Clobetasol

KW - Female

KW - Follow-Up Studies

KW - Glucocorticoids

KW - Humans

KW - Lupus Erythematosus, Systemic

KW - Male

KW - Middle Aged

KW - Occlusive Dressings

KW - Recurrence

KW - Retrospective Studies

KW - Single-Blind Method

KW - Surveys and Questionnaires

KW - Treatment Outcome

KW - Urticaria

KW - Urticaria Pigmentosa

M3 - Journal article

C2 - 8721491

SN - 0001-5555

VL - 76

SP - 43

EP - 44

JO - Acta Dermato-Venereologica

JF - Acta Dermato-Venereologica

IS - 1

ER -

Treatment of chronic idiopathic urticaria with topical steroids: An open trial.

Abstract

Keywords

Fingerprint

Cite this